Literature DB >> 10492266

Hypoxemia and hypercapnia during exercise and sleep in patients with cystic fibrosis.

S Bradley1, P Solin, J Wilson, D Johns, E H Walters, M T Naughton.   

Abstract

BACKGROUND: In patients with cystic fibrosis (CF), it has been proposed that hypoxemia and hypercapnia occur during episodes of stress, such as exercise and sleep, and that respiratory muscle weakness because of malnutrition may be responsible.
METHODS: Pulmonary function, respiratory muscle strength, and nutrition were assessed and correlated with the degree of hypoxemia and hypercapnia during exercise and sleep in 14 patients with CF and 8 control subjects.
RESULTS: Despite no differences in maximum static inspiratory pressure (PImax) between the two groups, the CF group developed more severe hypoxemia (minimum oxyhemoglobin saturation [SpO2], 89 +/- 5% vs 96 +/- 2%; p < 0.001) and hypercapnia (maximum transcutaneous CO2 tension [PtcCO2], 43 +/- 6 vs 33 +/- 7 mm Hg; p < 0.01) during exercise. Similarly, during sleep, the CF group developed greater hypoxemia (minimum SpO2, 82 +/- 8% vs 91 +/- 2%; p < 0.005), although CO2 levels were not significantly different (maximum PtcCO2, 48 +/- 7 vs 50 +/- 2 mm Hg). Within the CF group, exercise-related hypoxemia and hypercapnia did not correlate with FEV1, residual volume/total lung capacity ratio (RV/TLC), PImax, or body mass index (BMI). Hypoxemia and hypercapnia during sleep correlated with markers of gas trapping (RV vs minimum arterial oxygen saturation [r = -0.654; p < 0.05]), RV vs maximum PtcCO2 (r = 0.878; p < 0.001), and RV/TLC vs maximum PtcCO2 (r = 0.790; p < 0.01) but not with PImax or BMI.
CONCLUSION: Patients with moderately severe CF develop hypoxemia and hypercapnia during exercise and sleep to a greater extent than healthy subjects with similar respiratory muscle strength and nutritional status. Neither respiratory muscle weakness nor malnutrition are necessary to develop hypoxemia or hypercapnia during exercise or sleep.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10492266     DOI: 10.1378/chest.116.3.647

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  14 in total

Review 1.  Sleep disturbances and their impact in pediatric cystic fibrosis.

Authors:  Aarti Shakkottai; Louise M O'Brien; Samya Z Nasr; Ronald D Chervin
Journal:  Sleep Med Rev       Date:  2018-07-06       Impact factor: 11.609

2.  Sleep findings and predictors of sleep desaturation in adult cystic fibrosis patients.

Authors:  Christiano Perin; Simone C Fagondes; Fernanda C Casarotto; Antônio F F Pinotti; Sérgio S Menna Barreto; Paulo de Tarso R Dalcin
Journal:  Sleep Breath       Date:  2011-09-25       Impact factor: 2.816

Review 3.  Classification of sleep disorders.

Authors:  Michael J Thorpy
Journal:  Neurotherapeutics       Date:  2012-10       Impact factor: 7.620

Review 4.  Oxygen therapy for cystic fibrosis.

Authors:  Heather E Elphick; George Mallory
Journal:  Cochrane Database Syst Rev       Date:  2013-07-25

Review 5.  Assessment of hypoxia in children with cystic fibrosis.

Authors:  D S Urquhart; H Montgomery; A Jaffé
Journal:  Arch Dis Child       Date:  2005-11       Impact factor: 3.791

6.  Objective and Subjective Sleep Efficiency in Adult Patients with Cystic Fibrosis and Impact on Quality of Life.

Authors:  Marta Íscar-Urrutia; Claudia Janeth Madrid-Carbajal; Gemma Rubinos-Cuadrado; Ramón Fernández-Álvarez; María José Vázquez-López; Cristina Hernández-González; Ana Isabel Enríquez-Rodríguez; Marta García-Clemente
Journal:  Lung       Date:  2018-10-03       Impact factor: 2.584

7.  Sleep architecture in children and adolescents with cystic fibrosis and the association with severity of lung disease.

Authors:  S Kamal Naqvi; Carlos Sotelo; Lisa Murry; Narong Simakajornboon
Journal:  Sleep Breath       Date:  2008-03       Impact factor: 2.816

Review 8.  Sleep disorders in cystic fibrosis: A systematic review and meta-analysis.

Authors:  Joel Reiter; Alex Gileles-Hillel; Malena Cohen-Cymberknoh; Dennis Rosen; Eitan Kerem; David Gozal; Erick Forno
Journal:  Sleep Med Rev       Date:  2020-02-19       Impact factor: 11.609

9.  Relationship of sleep to pulmonary function in mucopolysaccharidosis II.

Authors:  William I Wooten; Joseph Muenzer; Bradley V Vaughn; Marianne S Muhlebach
Journal:  J Pediatr       Date:  2013-01-08       Impact factor: 4.406

10.  Determinants of exercise capacity in cystic fibrosis patients with mild-to-moderate lung disease.

Authors:  Jean Pastré; Anne Prévotat; Catherine Tardif; Carole Langlois; Alain Duhamel; Benoit Wallaert
Journal:  BMC Pulm Med       Date:  2014-04-30       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.